Yasaman Tamaddon

Harnessing stem cell-based therapies for Alzheimer’s disease: mechanism, challenges, and future perspectives

Alzheimer’s disease (AD) affects more than 55 million people worldwide, and current pharmacological treatments provide only modest symptomatic benefits with limited effects on disease progression. Stem cell-based therapies, including mesenchymal stem cells (MSCs), neural stem cel...